REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA.

Saved in:
Bibliographic Details
Title: REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMA.
Authors: Burger, M.1,2,3 (AUTHOR), Ehrend, E.4 (AUTHOR), Straßheimer, F.1,5 (AUTHOR), Cakmak, P.5,6 (AUTHOR), Krenzlin, H.7 (AUTHOR), Elleringmann, P.1,5 (AUTHOR), Zeiner, P.1,2,3 (AUTHOR), Herkt, S.C.4 (AUTHOR), Poschke, I.8,9 (AUTHOR), Macas, J.5,6 (AUTHOR), Weber, K.2,3,6 (AUTHOR), Schupp, J.5,6 (AUTHOR), Lun, J.5,6 (AUTHOR), Opitz, C.10 (AUTHOR), Roller, B.1,5 (AUTHOR), Manns, P.4 (AUTHOR), Klinsing, S.1,5 (AUTHOR), Breuer, S.11 (AUTHOR), Hehlgans, S.12 (AUTHOR), Lee, S.4 (AUTHOR)
Source: Cytotherapy (Elsevier Inc.). 2026 Supplement, Vol. 28 Issue 5, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:14653249
DOI:10.1016/j.jcyt.2026.102167